These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30719819)

  • 21. Clinical course and prognostic relevance of antitachycardia pacing-terminated ventricular tachyarrhythmias in implantable cardioverter-defibrillator patients.
    Kleemann T; Strauss M; Kouraki K; Zahn R
    Europace; 2015 Jul; 17(7):1068-75. PubMed ID: 25687746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eliminating right ventricular pacing may not be best for patients requiring implantable cardioverter-defibrillators.
    Olshansky B; Day JD; Lerew DR; Brown S; Stolen KQ;
    Heart Rhythm; 2007 Jul; 4(7):886-91. PubMed ID: 17599672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The reverse mode switch algorithm: how well does it work?
    Akerström F; Arias MA; Pachón M; Puchol A; Jiménez-López J; Rodríguez-Padial L
    Heart Rhythm; 2013 Aug; 10(8):1146-52. PubMed ID: 23732226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High prevalence of right ventricular dysfunction in ICD patients with shocks: a potential new predictor in risk stratification.
    Malasana G; Daccarett M; Kuppahally S; Wasmund SL; Litwin SE; Hamdan MH
    J Interv Card Electrophysiol; 2011 Aug; 31(2):165-9. PubMed ID: 21327491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D.
    Kutyifa V; Bloch Thomsen PE; Huang DT; Rosero S; Tompkins C; Jons C; McNitt S; Polonsky B; Shah A; Merkely B; Solomon SD; Moss AJ; Zareba W; Klein HU
    Heart Rhythm; 2013 Dec; 10(12):1770-7. PubMed ID: 23973954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined leadless pacemaker and subcutaneous implantable defibrillator therapy: feasibility, safety, and performance.
    Tjong FV; Brouwer TF; Smeding L; Kooiman KM; de Groot JR; Ligon D; Sanghera R; Schalij MJ; Wilde AA; Knops RE
    Europace; 2016 Nov; 18(11):1740-1747. PubMed ID: 26941338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Position paper for management of elderly patients with pacemakers and implantable cardiac defibrillators: Groupe de Rythmologie et Stimulation Cardiaque de la Société Française de Cardiologie and Société Française de Gériatrie et Gérontologie.
    Fauchier L; Alonso C; Anselme F; Blangy H; Bordachar P; Boveda S; Clementy N; Defaye P; Deharo JC; Friocourt P; Gras D; Halimi F; Klug D; Mansourati J; Obadia B; Pasquié JL; Pavin D; Sadoul N; Taieb J; Piot O; Hanon O
    Arch Cardiovasc Dis; 2016 Oct; 109(10):563-585. PubMed ID: 27595465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is ventricular sensing always right, when it is left?
    Biffi M; de Zan G; Massaro G; Angeletti A; Martignani C; Boriani G; Diemberger I; Ziacchi M
    Clin Cardiol; 2018 Sep; 41(9):1238-1245. PubMed ID: 30054904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experience with a third-generation implantable cardioverter-defibrillator.
    Saksena S; Mehta D; Krol RB; Tullo NG; Saxena A; Kaushik R; Neglia J
    Am J Cardiol; 1991 Jun; 67(16):1375-84. PubMed ID: 2042568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response of right ventricular size to treatment with cardiac resynchronization therapy and the risk of ventricular tachyarrhythmias in MADIT-CRT.
    Doyle CL; Huang DT; Moss AJ; Solomon SD; Campbell P; McNitt S; Polonsky S; Barsheshet A; Aktas M; Tompkins C; Zareba W; Goldenberg I
    Heart Rhythm; 2013 Oct; 10(10):1471-7. PubMed ID: 23872690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of hyperkalaemia on cardiac rhythm devices.
    Barold SS; Herweg B
    Europace; 2014 Apr; 16(4):467-76. PubMed ID: 24465006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patients treated with catheter ablation for ventricular tachycardia after an ICD shock have lower long-term rates of death and heart failure hospitalization than do patients treated with medical management only.
    Bunch TJ; Weiss JP; Crandall BG; Day JD; May HT; Bair TL; Osborn JS; Mallender C; Fischer A; Brunner KJ; Mahapatra S
    Heart Rhythm; 2014 Apr; 11(4):533-40. PubMed ID: 24333283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Right Bundle Branch Block-Like Pattern During Uncomplicated Right Ventricular Pacing and the Effect of Pacing Site.
    Tzeis S; Andrikopoulos G; Weigand S; Grebmer C; Semmler V; Brkic A; Asbach S; Kloppe A; Lennerz C; Bourier F; Pastromas S; Kolb C
    Am J Cardiol; 2016 Mar; 117(6):935-9. PubMed ID: 26796192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of atrial fibrillation with rapid ventricular rates and device programming on shocks in 106,513 ICD and CRT-D patients.
    Fischer A; Ousdigian KT; Johnson JW; Gillberg JM; Wilkoff BL
    Heart Rhythm; 2012 Jan; 9(1):24-31. PubMed ID: 21835150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.
    Almehmadi F; Porta-Sánchez A; Ha ACT; Fischer HD; Wang X; Austin PC; Lee DS; Nanthakumar K
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical implications of cumulative right ventricular pacing in the multicenter automatic defibrillator trial II.
    Steinberg JS; Fischer A; Wang P; Schuger C; Daubert J; McNitt S; Andrews M; Brown M; Hall WJ; Zareba W; Moss AJ;
    J Cardiovasc Electrophysiol; 2005 Apr; 16(4):359-65. PubMed ID: 15828875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of age (<75 Years versus ≥75 Years) to risk of ventricular tachyarrhythmias and implantable cardioverter defibrillator shocks (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
    Aktas MK; Goldenberg I; Moss AJ; Huang DT; Kutyifa V; Wang PJ; Brenyo A; McNitt S; Zareba W; Barsheshet A
    Am J Cardiol; 2014 Dec; 114(12):1855-60. PubMed ID: 25438913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy.
    Brouwer TF; Yilmaz D; Lindeboom R; Buiten MS; Olde Nordkamp LR; Schalij MJ; Wilde AA; van Erven L; Knops RE
    J Am Coll Cardiol; 2016 Nov; 68(19):2047-2055. PubMed ID: 27810043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arrhythmia rate distribution and tachyarrhythmia therapy in an ICD population: results from the INTRINSIC RV trial.
    Sullivan RM; Russo AM; Berg KC; Stolen KQ; Seth M; Perschbacher D; Day JD; Olshansky B
    Heart Rhythm; 2012 Mar; 9(3):351-8. PubMed ID: 22016074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.